Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
HCl
CAS Number:
Molecular Weight:
36.46
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12164502
EC Number:
231-595-7
MDL number:
Organoleptic:
faint
Grade:
Kosher
Biological source:
synthetic
Food allergen:
no known allergens
biological source
synthetic
grade
Kosher
reg. compliance
FCC
vapor pressure
190 mmHg ( 25 °C)
description
20 degrees baumé
form
liquid
concentration
32 wt. % in H2O
bp
100 °C (lit.)
density
1.161 g/mL at 25 °C
anion traces
sulfate (SO42-): ≤0.5%
cation traces
As: ≤3 ppm, Cd: ≤1 ppm, Fe: ≤5 ppm, Hg: ≤0.1 ppm, Pb: ≤1 ppm
application(s)
flavors and fragrances
documentation
see Safety & Documentation for available documents
food allergen
no known allergens
organoleptic
faint
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
General description
Hydrochloric acid solution (32 wt. % in H2O, FCC) is used in the food industry as pH adjusters and food additives (2).
Application
Hydrochloric acid solution is used as a pH adjuster:
- In the production of high fructose corn syrup (HFCS) during the process of converting corn starch to fructose.
- In the production of drinking water, beverages and foods. (2)
Disclaimer
For R&D or non-EU Food use. Not for retail sale.
Still not finding the right product?
Explore all of our products under Hydrochloric acid solution
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT SE 3
target_organs
Respiratory system
Storage Class
8B - Non-combustible corrosive hazardous materials
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Marta Kolodziejczak et al.
ACS chemical neuroscience, 6(7), 1219-1230 (2015-04-11)
Maturation of functional neuronal circuits during central nervous system development relies on sophisticated mechanisms. First, axonal and dendritic growth should reach appropriate targets for correct synapse elaboration. Second, pruning and neuronal death are required to eliminate redundant or inappropriate neuronal
Douglas M McMillan et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(7), 1804-1812 (2015-01-30)
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood-brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in
Davide R Ceratti et al.
Advanced materials (Deerfield Beach, Fla.), 27(34), 4958-4962 (2015-07-23)
A new, simple bi-phasic dip-coating method is developed. This method is considered as a great improvement of the technique for research, development and production, since expensive, rare, harmful, or time-evolving solutions can now be easily deposited on large surfaces and
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 63627-100MG | 04061832722580 |
| 8221610010 | 04022536485362 |
| S6881-10G | 04061836959630 |
| S6881-25G | 04061836959647 |
| S6881-100G | 04061836959623 |
| S6881-5G | 04061836959654 |
| W530574-1KG-K | 04061838027214 |
| W530574-500G-K | 04061837542688 |

